Globus Medical (GMED) Net Income towards Common Stockholders Growth (1y) (2012 - 2026)
Powered by 
Analysis
Globus Medical (GMED) Net Income towards Common Stockholders Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn | 12.92% |
| 10 | Globus Medical | 10.01 Bn | 9.42 Bn | 548.17 Mn | -25.28% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -25.28% |
| Mar 31, 2026 | 64.72% |
| Dec 31, 2025 | 430.44% |
| Sep 30, 2025 | 129.50% |
| Jun 30, 2025 | 538.68% |
| Mar 31, 2025 | 1,154.09% |
| Dec 31, 2024 | 76.30% |
| Sep 30, 2024 | 5,093.99% |
| Jun 30, 2024 | -44.97% |
| Mar 31, 2024 | -114.57% |
| Dec 31, 2023 | -52.98% |
| Sep 30, 2023 | -97.90% |
| Jun 30, 2023 | 5.72% |
| Mar 31, 2023 | 29.00% |
| Dec 31, 2022 | 1,610.86% |
| Sep 30, 2022 | 0.47% |
| Jun 30, 2022 | 31.40% |
| Mar 31, 2022 | -15.98% |
| Dec 31, 2021 | -97.59% |
| Sep 30, 2021 | 6.77% |